API Price Drop: Boost for Indian Pharma Profits! A sharp fall in API prices, driven by global overcapacity and China’s aggressive pricing, coupled with rising domestic production, offers significant margin respite for India’s pharmaceutical companies. Summary: India’s pharmaceutical sector is … Continue reading API Price Drop: Boost for Indian Pharma Profits!